Research Article
The Impact of Training Residents on the Outcome of Robotic-Assisted Sacrocolpopexy
Table 1
Patient/clinical demographics overall and by group, P value is comparison between groups.
| | Overall | Group 1 () | Group 2 () | P value |
| Age (years), median (IQR) | 61.5 (15) | 61 (12) | 63 (16) | .744 | Race | | | | .395 | Caucasian | 29 (71%) | 12 (60%) | 17 (81%) | | African American | 4 (10%) | 3 (15%) | 1 (5%) | | Hispanic | 1 (2%) | 1 (5%) | 0 | | Unknown | 7 (17%) | 4 (20%) | 3 (14%) | | BMI, mean (SD) | 28.6 (12.7) | 29.0 (25.9) | 27.1 (9.3) | .754 | Stage | | | | .488 | III | 39 (95%) | 20 (100%) | 19 (91%) | | IV | 2 (5%) | 0 | 2 (9%) | | Prior prolapse surgery (yes) | 2 (5%) | 0 | 2 (10%) | .488 | Prior incontinence surgery (yes) | 6 (15%) | 2 (10%) | 4 (19%) | .663 | Burch | 1 | 1 | 0 | | TVT | 2 | 0 | 2 | | Rectus FS | 1 | 1 | 0 | | Other | 2 | 0 | 2 | | Menopause (yes) | 34 (83%) | 18 (90%) | 16 (76%) | .410 | Selected comorbidities | | | | | Diabetes | 3 (7%) | 2 (10%) | 1 (5%) | | COPD/Asthma | 2 (5%) | 2 (10%) | 0 | | CAD | 1 (2%) | 1 (5%) | 0 | | HTN | 10 (24%) | 8 (40%) | 2 (10%) | | Cancer | 4 (10%) | 4 (20%) | 0 | | Current steroid use | 1 (2%) | 1 (5%) | 0 | .488 |
|
|